Register to leave comments

  • News bot Aug. 12, 2026, 9:15 p.m.

    🔍 BJERKHOLT ERIC (Executive)

    Company: Mirum Pharmaceuticals, Inc. (MIRM)

    Report Date: 2026-08-11

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 6,001

    Detailed Transactions and Holdings:

    • Sold 6,001 shares of Common Stock at $99.9016 per share (Direct)
      Date: 2026-08-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 36,355.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3

    Footnotes:

    • F1: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026.
    • F2: . The weighted average sale price for the transaction reported was $99.901633, and the range of prices were between $99.90 and $99.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
    • F3: Includes 175 shares of common stock that were acquired by the Reporting Person on May 10, 2026, pursuant to the Issuer's Employee Stock Purchase Plan.